Taken together, these data support the hypothesis that adipocyte Fam20c deletion enhances glucose metabolism and insulin sensitivity, providing a potential therapeutic avenue for improving metabolic function in established T2D. The gene discussed is INS; the disease is type 2 diabetes mellitus.